CEOInterviews.AI
Start App
Try: AI strategy tariffs earnings guidance layoffs interest rates growth

Peter Griffith

Executive VP & CFO, Amgen

Verified interview transcripts, podcast appearances, and direct quotes from Peter Griffith, Executive VP & CFO at Amgen. AI-verified speaker identity with full-text searchable transcripts.

Recent appearances

  • Amgen Q4 2025 Earnings Call

    February 16, 2026 · 📺 i101

    Amgen Q4 2025 Earnings Call If you find our work useful, please support us by purchasing a Super Thanks— it truly helps us a lot. #earningscall #StockMarketNews #conferenceCall Earnings Call | Earnings Conference Call | Earnings concall | concall | quarterly results | Stock News | Full Year results | Fiscal Year results | investment news | stock latest news If you want us to remove your company's earnings call or any other conference call, please reach out to [email protected].

    Watch on YouTube ↗

  • $AMGN Amgen Inc Q2 2025 Earnings Conference Call

    August 05, 2025 · 📺 EARNMOAR

    08/05/2025 Q&A: 26:12 Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behcet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the tr…

    Watch on YouTube ↗

  • Amgen CFO talks Q2 earnings, obesity drug, and growth

    August 06, 2024 · 📺 Yahoo Finance

    Amgen (AMGN) posted second quarter revenue of $8.4 billion, topping expectations of $8.34 billion. Sales rose by 20% in the quarter, however, the company noted that lower net selling prices partially offset a 26% growth in volume for products. Amgen Chief Financial Officer Peter Griffith joins Market Domination Overtime to break down the company's latest earnings report and its outlook amid mounting fears of a recession. Griffith notes that 12 of Amgen's products delivered double-digit sales growth during its second quarter, and he expects that growth to continue in the second half of the year…

    Watch on YouTube ↗

Other executives at Amgen

The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →